Dr. Reddy’s and Alvotech shared that the Food and Drug Administration has accepted a 351(k) Biologic License Application submission for AVT03, which was developed by Alvotech, and is a proposed ...
Boncresa is supplied as a 60 mg/mL single-dose prefilled syringe for SC injection and Oziltus is supplied as a 120 mg/1.7 mL single-dose vial for SC injection. Boncresa is approved to treat ...
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ ...
Dr. Reddy’s Laboratories (NYSE:RDY) and Alvotech (NASDAQ:ALVO) announced that the U.S. FDA has accepted a Biologic License Application submission for AVT03, a biosimilar targeting Amgen's (NASDAQ:AMGN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results